by Steve Lundeberg, Oregon State University Credit: Pharmaceutics (2022). DOI: 10.3390/pharmaceutics14040713 Research by Oregon State University has uncovered a potential new therapy for pancreatic cancer, whose survival rate is among the lowest of all malignancies. About one person in 64 will be diagnosed with pancreatic cancer, according to the American Cancer Society. The pancreas is an abdominal...
UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER HOUSTON ― A multicenter research team co-led by The University of Texas MD Anderson Cancer Center developed the first drug to treat the uncontrolled secretion of mucins in the airways, which causes potentially life-threatening symptoms in millions of Americans with asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis...
by Massachusetts General Hospital Credit: Unsplash/CC0 Public Domain In a recent study published in Nature Biomedical Engineering, a team led by researchers at Massachusetts General Hospital (MGH) has demonstrated that magnetic resonance imaging (MRI) and artificial intelligence (AI) can be used to detect early signs of tumor cell death in response to a novel virus-based cancer...
Hepatocyte growth factor (HGF) could reduce the risk of bone fracture for people living with type 2 diabetes and hypertension, according to a new study from an international team of researchers at The University of Texas at Arlington and the University of Saskatchewan (USask). The study, titled “Hepatocyte growth factor administration increases bone soluble phosphate...
by Melissa Rohman, Northwestern University Glioma of the left parietal lobe. CT scan with contrast enhancement. Credit: Mikhail Kalinin/CC BY-SA 3.0 A novel therapy engineered by Northwestern Medicine investigators improved progression-free and overall survival for patients with newly diagnosed malignant gliomas, according to results from a recent phase I clinical trial published in The Lancet Oncology. In...
by The Mount Sinai Hospital Credit: Pixabay/CC0 Public Domain Mount Sinai researchers have developed a therapeutic agent that shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive, according to a paper published in Cancer Discovery, a journal of the American Association for Cancer Research, in July. The therapy is an engineered molecule, named MS21, that...
